Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-23-041603
Filing Date
2023-08-11
Accepted
2023-08-11 07:30:54
Documents
73
Period of Report
2023-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q dbtx-20230630.htm   iXBRL 10-Q 3230007
2 EX-3.1 dbtx-ex3_1.htm EX-3.1 108130
3 EX-31.1 dbtx-ex31_1.htm EX-31.1 20962
4 EX-31.2 dbtx-ex31_2.htm EX-31.2 21279
5 EX-32.1 dbtx-ex32_1.htm EX-32.1 10983
6 EX-32.2 dbtx-ex32_2.htm EX-32.2 11320
  Complete submission text file 0000950170-23-041603.txt   10195203

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT dbtx-20230630_pre.xml EX-101.PRE 336003
8 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT dbtx-20230630.xsd EX-101.SCH 54103
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT dbtx-20230630_def.xml EX-101.DEF 201081
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT dbtx-20230630_cal.xml EX-101.CAL 51965
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT dbtx-20230630_lab.xml EX-101.LAB 468611
67 EXTRACTED XBRL INSTANCE DOCUMENT dbtx-20230630_htm.xml XML 1788077
Mailing Address 1325 BOYLSTON STREET SUITE 500 BOSTON MA 02215
Business Address 1325 BOYLSTON STREET SUITE 500 BOSTON MA 02215 617-370-8701
Decibel Therapeutics, Inc. (Filer) CIK: 0001656536 (see all company filings)

EIN.: 464198709 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40030 | Film No.: 231161529
SIC: 2834 Pharmaceutical Preparations